MYCN and neuroblastoma: Particularly, MYCN upregulates DNA repair genes, reduce apoptosis, and increase the expression of drug efflux pumps to promote treatment resistance [9, 10], even modulates immune microenvironment by downregulating the expression of immune‐stimulatory molecules and upregulating immune checkpoint proteins, helping NB cells evade immune surveillance [11].